IRulya Therapeutics (IRLA) Return on Equity [ROE] (2019 - 2025)
IRulya Therapeutics (IRLA) reported Return on Equity [ROE] of -890.64% for Q3 2025, down 774.73 percentage points from -115.92% a year earlier and down 567.20 percentage points from the prior quarter.
IRulya Therapeutics (IRLA) Return on Equity [ROE] (2019 - 2025) Analysis & Trends
For FY2024, IRulya Therapeutics posted Return on Equity [ROE] of -98.63%, down 64.83 percentage points from FY2023.
- Return on Equity [ROE] has a five-year change of -9.37 percentage points (FY2019 to FY2024).
- By year, Return on Equity [ROE] came in at -33.81% in FY2023 (+13.33 pp), -47.14% in FY2022 and -53.42% in FY2020 (+35.85 pp).
- The Q3 2025 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q2 2019.
- Year over year, Return on Equity [ROE] has now declined in each of the last six quarters, with an average year-over-year change of -181.56 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2022 (a gain of 82.31 percentage points); the low point was Q3 2025 (a drop of 774.73 percentage points).
- Per Business Quant data, the three quarters before Q3 2025 came in at -323.44% (Q2 2025), -249.18% (Q1 2025) and -151.38% (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.66% |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -890.64% |
| Jun 30, 2025 | -323.44% |
| Mar 31, 2025 | -249.18% |
| Dec 31, 2024 | -151.38% |
| Sep 30, 2024 | -115.92% |
| Jun 30, 2024 | -87.70% |
| Mar 31, 2024 | -38.03% |
| Dec 31, 2023 | -37.31% |
| Sep 30, 2023 | -32.97% |
| Jun 30, 2023 | -34.55% |
| Mar 31, 2023 | -44.31% |
| Dec 31, 2022 | -50.37% |
| Sep 30, 2022 | 18.90% |
| Jun 30, 2022 | 6.09% |
| Mar 31, 2022 | 1.28% |
| Sep 30, 2021 | -63.41% |
| Jun 30, 2021 | -58.21% |
| Mar 31, 2021 | -50.35% |
| Dec 31, 2020 | -42.66% |
| Sep 30, 2020 | -34.91% |
IRulya Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRLA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();